Perryman Financial Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Buy
2,398
+409
+21% +$418K 0.38% 59
2026
Q1
$1.83M Buy
1,989
+59
+3% +$59.8K 0.27% 67
2025
Q4
$2.07M Buy
+1,930
New +$1.85M 0.3% 65

Other funds holding LLY

Perryman Financial Advisory's LLY Position: Q2 2026 in Review

Perryman Financial Advisory increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $418K and bringing the position to 2,398 shares worth $2.88M. The position accounts for 0.38% of the portfolio, ranked #59.

Perryman Financial Advisory first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Perryman Financial Advisory held 2,398 shares of Eli Lilly worth $2.88M as of Q2 2026.
  • Perryman Financial Advisory bought 409 Eli Lilly shares in Q2 2026, an estimated $418K.
  • Eli Lilly made up 0.38% of Perryman Financial Advisory's portfolio in Q2 2026, its #59 holding.
  • Perryman Financial Advisory first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Perryman Financial Advisory's 13F filing for Q2 2026, filed 24 Jul 2026.